{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T05:47:54Z","timestamp":1785044874699,"version":"3.55.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejim.2022.05.002","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T03:39:55Z","timestamp":1653449995000},"page":"14-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation"],"prefix":"10.1016","volume":"101","author":[{"given":"Dirk Jan","family":"van Ginkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem L.","family":"Bor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Veenstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2344-7564","authenticated-orcid":false,"given":"Arnoud W.J.","family":"van 't Hof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9458-0736","authenticated-orcid":false,"given":"Enrico","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2022.05.002_bib0001","volume":"143","author":"Otto","year":"2021"},{"issue":"7","key":"10.1016\/j.ejim.2022.05.002_bib0002","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.ejim.2022.05.002_bib0003","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ejim.2022.05.002_bib0004","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ejim.2022.05.002_bib0005","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ejim.2022.05.002_bib0006","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ejim.2022.05.002_bib0007","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s12471-021-01638-8","article-title":"Major threats to early safety after transcatheter aortic valve implantation in a contemporary cohort of real-world patients","volume":"29","author":"van Ginkel","year":"2021","journal-title":"Neth Heart J"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.002_bib0008","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1911425","article-title":"A controlled trial of rivaroxaban after transcatheter aortic-valve replacement","volume":"382","author":"Dangas","year":"2020","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ejim.2022.05.002_bib0009","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ejim.2022.05.002_bib0010","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without clopidogrel after transcatheter aortic-valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.002_bib0011","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1053\/j.jvca.2017.08.034","article-title":"Stroke after transcatheter aortic valve replacement: incidence, definitions, etiologies and management options","volume":"32","author":"Patel","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"17","key":"10.1016\/j.ejim.2022.05.002_bib0012","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ejim.2022.05.002_bib0013","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.ejim.2022.05.002_bib0014","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.jacc.2015.03.014","article-title":"Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis","volume":"65","author":"Thyregod","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ejim.2022.05.002_bib0015","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jcin.2017.01.045","article-title":"Clinical bioprosthetic heart valve thrombosis after transcatheter aortic valve replacement","volume":"10","author":"Jose","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejim.2022.05.002_bib0016","volume":"12","author":"Vlastra","year":"2019"},{"key":"10.1016\/j.ejim.2022.05.002_bib0017","series-title":"Anticoagulation after transcatheter aortic valve implantation: current status","first-page":"15","author":"Greco","year":"2020"},{"issue":"5","key":"10.1016\/j.ejim.2022.05.002_bib0018","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jcin.2015.01.020","article-title":"Incidence and predictors of debris embolizing to the brain during transcatheter aortic valve implantation","volume":"8","author":"van Mieghem","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"17","key":"10.1016\/j.ejim.2022.05.002_bib0019","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jcin.2018.06.018","article-title":"Significant differences in debris captured by the sentinel dual-filter cerebral embolic protection during transcatheter aortic valve replacement among different valve types","volume":"11","author":"Seeger","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.ejim.2022.05.002_bib0020","doi-asserted-by":"crossref","first-page":"e1047","DOI":"10.4244\/EIJY15M11_12","article-title":"A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation","volume":"12","author":"Sannino","year":"2016","journal-title":"EuroIntervention"},{"issue":"45","key":"10.1016\/j.ejim.2022.05.002_bib0021","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1093\/eurheartj\/ehx390","article-title":"Thrombo-embolic prevention after transcatheter aortic valve implantation","volume":"38","author":"Vranckx","year":"2017","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.ejim.2022.05.002_bib0022","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.117.029479","article-title":"The fluid mechanics of transcatheter heart valve leaflet thrombosis in the neosinus","volume":"136","author":"Midha","year":"2017","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ejim.2022.05.002_bib0023","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jacc.2019.08.1032","article-title":"Thrombotic versus bleeding risk after transcatheter aortic valve replacement","volume":"74","author":"Mangieri","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2022.05.002_bib0024","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejim.2020.07.010","article-title":"The CHA2DS2-VASc score and geriatric multidimensional assessment tools in elderly patients with persistent atrial fibrillation undergoing electrical cardioversion. A link with arrhythmia relapse?","volume":"82","author":"Fumagalli","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1016\/j.ejim.2022.05.002_bib0025","first-page":"463","article-title":"Use of the reported Edmonton frail scale in the assessment of patients for transcatheter aortic valve replacement: a possible selection tool in very high-risk patients?","volume":"15","author":"Koizia","year":"2018","journal-title":"J Geriatr Cardiol [Internet]"},{"issue":"14","key":"10.1016\/j.ejim.2022.05.002_bib0026","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.jcin.2017.04.034","article-title":"Frequency, timing, and impact of access-site and non\u2013access-site bleeding on mortality among patients undergoing transcatheter aortic valve replacement","volume":"10","author":"Piccolo","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.ejim.2022.05.002_bib0027","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/14779072.2021.1924678","article-title":"Trends, predictors, and outcomes of major bleeding after transcatheter aortic valve implantation, from national inpatient sample (2011\u20132018)","volume":"19","author":"Zahid","year":"2021","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"4","key":"10.1016\/j.ejim.2022.05.002_bib0028","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.amjcard.2017.05.035","article-title":"Meta-analysis of predictors of early severe bleeding in patients who underwent transcatheter aortic valve implantation","volume":"120","author":"Sun","year":"2017","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.ejim.2022.05.002_bib0029","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jcin.2020.01.238","article-title":"Frailty and bleeding in older adults undergoing TAVR or SAVR","volume":"13","author":"Bendayan","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejim.2022.05.002_bib0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejim.2020.05.027","article-title":"Kidney dysfunction and short term all-cause mortality after transcatheter aortic valve implantation","volume":"81","author":"Sgura","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"10","key":"10.1016\/j.ejim.2022.05.002_bib0031","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2459\/JCM.0000000000001014","article-title":"Morphometric and traditional frailty assessment in transcatheter aortic valve implantation","volume":"21","author":"Waduud","year":"2020","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"21","key":"10.1016\/j.ejim.2022.05.002_bib0032","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10215046","article-title":"Vascular complications in TAVR: incidence, clinical impact, and management","volume":"10","author":"Mach","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.002_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2018.09.041","article-title":"Blood disorders in patients undergoing transcatheter aortic valve replacement","volume":"12","author":"de Larochelli\u00e8re","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.ejim.2022.05.002_bib0034","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa022831","article-title":"Acquired von willebrand syndrome in aortic stenosis","volume":"349","author":"Vincentelli","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejim.2022.05.002_bib0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40266-018-0550-6","article-title":"Potential Drug-Drug Interactions in a Cohort of Elderly, Polymedicated Primary Care Patients on Antithrombotic Treatment","volume":"35","author":"Schneider","year":"2018","journal-title":"Drugs Aging"},{"issue":"23","key":"10.1016\/j.ejim.2022.05.002_bib0036","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehab196","volume":"42","author":"ten Berg","year":"2021","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ejim.2022.05.002_bib0037","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.ejim.2022.05.002_bib0038","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jcin.2017.04.014","article-title":"Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve","volume":"10","author":"Rod\u00e9s-Cabau","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.ejim.2022.05.002_bib0039","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.amjcard.2019.01.049","article-title":"Usefulness of clopidogrel loading in patients who underwent transcatheter aortic valve implantation (from the BRAVO-3 Randomized Trial)","volume":"123","author":"Nijenhuis","year":"2019","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.ejim.2022.05.002_bib0040","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.amjcard.2018.12.042","article-title":"Continued versus interrupted oral anticoagulation during transfemoral transcatheter aortic valve implantation and impact of postoperative anticoagulant management on outcome in patients with atrial fibrillation","volume":"123","author":"Mangner","year":"2019","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.002_bib0041","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jcin.2020.09.062","article-title":"Safety and efficacy of transcatheter aortic valve replacement with continuation of vitamin K antagonists or direct oral anticoagulants","volume":"14","author":"Brinkert","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.ejim.2022.05.002_bib0042","doi-asserted-by":"crossref","first-page":"e1392","DOI":"10.4244\/EIJ-D-17-00198","article-title":"Which is the best antiaggregant or anticoagulant therapy after TAVI? A propensity-matched analysis from the ITER registry. The management of DAPT after TAVI","volume":"13","author":"D'Ascenzo","year":"2017","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.002_bib0043","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcin.2016.10.023","article-title":"Apixaban in patients with atrial fibrillation after transfemoral aortic valve replacement","volume":"10","author":"Seeger","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.ejim.2022.05.002_bib0044","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00392-018-1247-x","article-title":"Bekeredjian R. NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation","volume":"107","author":"Geis","year":"2018","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.002_bib0045","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12471-013-0496-6","article-title":"Antithrombotic therapy in patients undergoing TAVI: an overview of Dutch hospitals","volume":"22","author":"Nijenhuis","year":"2014","journal-title":"Neth Heart J"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.002_bib0046","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcin.2020.10.026","article-title":"Oral anticoagulation continuation throughout TAVR","volume":"14","author":"Auffret","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"25","key":"10.1016\/j.ejim.2022.05.002_bib0047","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.jacc.2015.10.003","article-title":"Bivalirudin versus heparin anticoagulation in transcatheter aortic valve replacement","volume":"66","author":"Dangas","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2022.05.002_bib0048","first-page":"2869","volume":"Vol. 66","author":"Rao","year":"2015"},{"issue":"12","key":"10.1016\/j.ejim.2022.05.002_bib0049","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jcin.2020.03.041","article-title":"Safety and efficacy of protamine administration for prevention of bleeding complications in patients undergoing TAVR","volume":"13","author":"Al-Kassou","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.ejim.2022.05.002_bib0050","doi-asserted-by":"crossref","first-page":"995","DOI":"10.33963\/KP.a2021.0070","article-title":"Protamine sulfate during transcatheter aortic valve implantation (PS TAVI) \u2014 a single-center, single-blind, randomized placebo-controlled trial","volume":"79","author":"Zbro\u0144ski","year":"2021","journal-title":"Kardiol Pol"},{"issue":"3","key":"10.1016\/j.ejim.2022.05.002_bib0051","first-page":"306","article-title":"Use of protamine sulfate during transfemoral transcatheter aortic valve implantation \u2013 a preliminary assessment of administration rate and impact on complications","volume":"16","author":"Zbro\u0144ski","year":"2020","journal-title":"Adv Interv Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.002_bib0052","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/bjh.12107","article-title":"Guideline on the management of bleeding in patients on antithrombotic agents","volume":"160","author":"Makris","year":"2013","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.ejim.2022.05.002_bib0053","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.bja.2018.01.023","article-title":"Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review","volume":"120","author":"Boer","year":"2018","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.002_bib0054","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1911426","article-title":"Reduced leaflet motion after transcatheter aortic-valve replacement","volume":"382","author":"de Backer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.05.002_bib0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2018.03.008","article-title":"Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial","volume":"200","author":"Collet","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2022.05.002_bib0056","series-title":"Anti-thrombotic strategy to lower all cardiovascular and neurologic ischemic and hemorrhagic events after trans-aortic valve implantation for aortic stenosis\u00a0: a randomized, open-label","author":"Collet","year":"2021"},{"key":"10.1016\/j.ejim.2022.05.002_bib0057","series-title":"Apixaban and valve thrombosis after transcatheter aortic valve implantation: The ATLANTIS-4D-CT substudy","author":"Montalescot","year":"2021"},{"key":"10.1016\/j.ejim.2022.05.002_bib0058","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ahj.2015.11.008","article-title":"Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation","volume":"173","author":"Nijenhuis","year":"2016","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.ejim.2022.05.002_bib0059","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019604","article-title":"Aspirin alone versus dual antiplatelet therapy after transcatheter aortic valve implantation: a systematic review and patient-level meta-analysis","volume":"10","author":"Brouwer","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.ejim.2022.05.002_bib0060","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019490","article-title":"Duration of antiplatelet therapy following transcatheter aortic valve replacement: systematic review and network meta-analysis","volume":"10","author":"Kuno","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2022.05.002_bib0061","volume":"8","author":"Zhang","year":"2021"},{"issue":"16","key":"10.1016\/j.ejim.2022.05.002_bib0062","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jcin.2019.03.003","article-title":"Oral anticoagulant type and outcomes after transcatheter aortic valve replacement","volume":"12","author":"Jochheim","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.002_bib0063","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ehjcvp\/pvz064","article-title":"Vitamin K antagonists vs. direct oral anticoagulants after transcatheter aortic valve implantation in atrial fibrillation","volume":"7","author":"Butt","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"issue":"22","key":"10.1016\/j.ejim.2022.05.002_bib0064","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.jcin.2020.09.013","article-title":"Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after TAVR","volume":"13","author":"Kawashima","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejim.2022.05.002_bib0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ahj.2018.07.006","article-title":"Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation\u2014Rationale and design of the ENVISAGE-TAVI AF trial","volume":"205","author":"van Mieghem","year":"2018","journal-title":"Am Heart J"},{"issue":"23","key":"10.1016\/j.ejim.2022.05.002_bib0066","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","article-title":"Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR","volume":"385","author":"van Mieghem","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.05.002_bib0067","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2147\/IJNRD.S105771","article-title":"Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations","volume":"10","author":"Lutz","year":"2017","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"19","key":"10.1016\/j.ejim.2022.05.002_bib0068","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/eurheartj\/ehaa799","article-title":"Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"42","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ejim.2022.05.002_bib0069","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.001779","article-title":"Treatment and clinical outcomes of transcatheter heart valve thrombosis","volume":"8","author":"Latib","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.ejim.2022.05.002_bib0070","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.006730","article-title":"Clinical valve thrombosis after transcatheter aortic valve-in-valve implantation","volume":"11","author":"Abdel-Wahab","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejim.2022.05.002_bib0071","volume":"6","author":"Rosseel","year":"2019"},{"issue":"2","key":"10.1016\/j.ejim.2022.05.002_bib0072","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1911426","article-title":"Reduced leaflet motion after transcatheter aortic-valve replacement","volume":"382","author":"de Backer","year":"2020","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ejim.2022.05.002_bib0073","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.jacc.2020.04.043","article-title":"Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves","volume":"75","author":"Makkar","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.ejim.2022.05.002_bib0074","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.jacc.2020.03.022","article-title":"Bioprosthetic aortic valve leaflet thickening in the evolut low risk sub-study","volume":"75","author":"Blanke","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ejim.2022.05.002_bib0075","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/ejcts\/ezz099","article-title":"Incidence, predictors and cerebrovascular consequences of leaflet thrombosis after transcatheter aortic valve implantation: a systematic review and meta-analysis","volume":"56","author":"D'Ascenzo","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"issue":"15","key":"10.1016\/j.ejim.2022.05.002_bib0076","doi-asserted-by":"crossref","first-page":"e1748","DOI":"10.4244\/EIJ-D-17-01062","article-title":"Bioprosthetic aortic valve leaflet thrombosis detected by multidetector computed tomography is associated with adverse cerebrovascular events: a meta-analysis of observational studies","volume":"13","author":"Rashid","year":"2018","journal-title":"EuroIntervention"},{"issue":"21","key":"10.1016\/j.ejim.2022.05.002_bib0077","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1509233","article-title":"Possible subclinical leaflet thrombosis in bioprosthetic aortic valves","volume":"373","author":"Makkar","year":"2015","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.ejim.2022.05.002_bib0078","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.jacc.2016.08.010","article-title":"Transcatheter aortic valve thrombosis","volume":"68","author":"Hansson","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"28","key":"10.1016\/j.ejim.2022.05.002_bib0079","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/eurheartj\/ehv526","article-title":"Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves","volume":"37","author":"Pache","year":"2016","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.ejim.2022.05.002_bib0080","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/eurheartj\/ehx031","article-title":"Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke","volume":"38","author":"Vollema","year":"2017","journal-title":"Eur Heart J"},{"issue":"10087","key":"10.1016\/j.ejim.2022.05.002_bib0081","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(17)30757-2","article-title":"Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study","volume":"389","author":"Chakravarty","year":"2017","journal-title":"Lancet North Am Ed"},{"issue":"1","key":"10.1016\/j.ejim.2022.05.002_bib0082","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jcct.2017.11.002","article-title":"Leaflet thrombosis following transcatheter aortic valve implantation","volume":"12","author":"Marwan","year":"2018","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.ejim.2022.05.002_bib0083","first-page":"792","volume":"104","author":"Doris","year":"2018"},{"key":"10.1016\/j.ejim.2022.05.002_bib0084","first-page":"947","volume":"91","author":"Yahagi","year":"2018"},{"key":"10.1016\/j.ejim.2022.05.002_bib0085","first-page":"1048","volume":"90","author":"Yahagi","year":"2017"},{"issue":"12","key":"10.1016\/j.ejim.2022.05.002_bib0086","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.amjcard.2011.07.049","article-title":"Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation","volume":"108","author":"Ussia","year":"2011","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ejim.2022.05.002_bib0087","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijcard.2014.04.170","article-title":"SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation","volume":"174","author":"Stabile","year":"2014","journal-title":"Int J Cardiol"},{"issue":"13","key":"10.1016\/j.ejim.2022.05.002_bib0088","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jcin.2017.04.014","article-title":"Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve","volume":"10","author":"Rod\u00e9s-Cabau","year":"2017","journal-title":"JACC Cardiovasc Interv"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522001716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522001716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:35:40Z","timestamp":1760607340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620522001716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":88,"alternative-id":["S0953620522001716"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2022.05.002","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2022.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}